Particle Therapy Market

Particle Therapy Market (Therapy: Proton Therapy, and Heavy Ion Therapy; and Services: Cyclotrons, Synchrotrons, and Synchrocyclotrons) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Particle Therapy Market Outlook

  • The global industry was valued at US$ 603.5 Mn in 2022
  • It is projected to grow at a CAGR of 8.6% from 2023 to 2031 and reach more than US$ 1.3 Bn by the end of 2031

Analysts’ Viewpoint

Escalating cancer prevalence and the increase in integration of radiation therapy as a key element in cancer treatment is expected to bolster the particle therapy market growth. Technology advancement and ongoing research endeavors have amplified the efficacy and safety of particle therapy, making it an appealing choice for both patients and healthcare providers.

Furthermore, the advantages of particle therapy, including less harm to healthy tissues and reduced long-term side effects propels its adoption. Government initiatives and financial backing to improve healthcare technologies, including the establishment of particle therapy facilities, also fuels market development.

Key industry players have established proton therapy centers worldwide. The surge in collaborations and partnerships between healthcare entities and research institutions aimed at broadening access to particle therapy services also contributes significantly to market expansion.

Market Outlook

Particle therapy, a form of external beam radiation therapy, harnesses heavy particle beams in treatments such as proton and carbon ion therapy. Particularly effective for tumors situated near critical structures such as the brain or spine and confined to their original site, the therapy holds promise, especially for younger patients. It mitigates damage to healthy, developing tissue and minimizes long-term radiation therapy side effects.

Technological advancements in radiation therapy have enabled precise targeting, minimizing radiation exposure to healthy tissue. Particle therapy employs highly charged particles that deposit the majority of radiation directly into the tumor, sparing surrounding healthy tissue from significant exposure.

Proton therapy, the most rampant particle therapy modality, utilizes protons to generate radiation beams. According to the Particle Therapy Co-Operative Group (PTCOG) website, approximately 360,000 patients worldwide have undergone particle therapy treatments from 1975 to 2022.

Attribute Detail
Drivers
  • Rise in Adoption of Particle Therapy in Clinical Trials
  • Surge in Number of Cancer Patients

Rise in Adoption of Particle Therapy in Clinical Trials Fueling Particle Therapy Market Size

The frequency of cancer surgical procedures has seen an uptick in recent years, leading to a corresponding rise in adoption of particle therapy to address post-surgical consequences. Particle beams possess unique physical properties that enable the preservation of normal tissue by minimizing the irradiated volume. This approach, grounded in radiobiological principles and supported by clinical data from photon therapy, holds promise for reducing the risk and severity of side effects, as well as secondary cancers.

Furthermore, particle therapy is gaining traction in clinical trials for the treatment of various cancers without surgical intervention or specific drug indications. The Medical Service Advisory Committee (MSAC) is currently evaluating the clinical indications for particle therapy, previously approved under the Australian Government's Medical Treatment Overseas Program (MTOP). Although the efficacy of particle therapy, utilizing either protons or ions, for individual tumor types is still under investigation, its introduction into clinical practice offers a novel avenue for enhancing cancer sensitivity to radiotherapy. Thus, the surge in usage in clinical trials is driving the particle therapy market value.

Surge in Number of Cancer Patients Boosting Particle Therapy Market Demand

Cancer treatment encompasses various therapeutic approaches involving potent chemicals (chemotherapy) and powerful radiation (radiotherapy and proton therapy) aimed at eradicating cancerous cells within the body.

According to the GLOBOCAN 2020 estimates by the International Agency for Research on Cancer, there were approximately 19.3 million new cancer cases (excluding non-melanoma skin cancer) and nearly 10.0 million cancer-related deaths in 2020 worldwide.

The significant increase in incidence of cancer cases globally is expected to offer lucrative particle therapy market opportunities in the next few years. By 2040, it is anticipated that the global burden of cancer will surge to 27.5 million new cases and 16.3 million cancer-related deaths, largely propelled by the aging population.

Hospitals are central hubs for all treatment procedures, including particle therapy. The rise in number of cancer cases, which increases the admission of patients in hospitals, and macroeconomic success in providing particle therapy services using protons and electrons for treating cancers are likely to drive the hospital segment in terms of end-user in the particle therapy market during the forecast period.

All these factors are poised to be key drivers for particle therapy market growth throughout the forecast period.

Therapeutic Benefits of Proton Therapy

The particle therapy market segmentation in terms of therapy includes proton therapy and heavy ion. Proton therapy has significant prominence within the particle therapy Industry. The increase in need for radiation therapy in cancer treatment, supported by favorable outcomes from clinical research emphasizes the efficacy of proton particle-beam therapies.

Furthermore, ongoing research endeavors are revealing the distinctive biological, immunomodulatory, and clinical impacts of protons, underscoring their unique properties relative to photons.

High Demand for Cyclotrons

Based on services, the market is classified into cyclotrons, synchrotrons, and synchrocyclotrons. As per the particle therapy market analysis, cyclotrons have been integral to the landscape of radiotherapy since its early inception, and they are poised to play a significant role in future hospital-based facilities tailored for this purpose.

Modern cyclotron technology has evolved to fulfill all necessary requirements while remaining within reasonable budget constraints. Various cyclotron designs with specific performance capabilities are available to meet diverse needs. Cyclotrons have become a predominant choice for particle accelerators in particle therapy treatment due to their affordability and the abundance of technical expertise available. Majority of proton accelerators in operation currently are cyclotrons, as they can generate a continuous stream of protons, are more compact, and offer higher beam intensity compared to other alternatives.

Regional Outlook of Particle Therapy Industry

Attribute Detail
Leading Region North America

According to the latest particle therapy market forecast, North America commands a significant share of the landscape, ascribed to the establishment of numerous laboratories in the U.S. and Canada. Statistics from surgery data indicate that 40% to 50% of patients receiving particle therapy treatment worldwide are treated in North America. The surge in usage of cyclotron technology to treat various types of cancers, and the growth in demand for advanced healthcare techniques and patient diagnosis, is anticipated to fuel market growth in this region during the forecast period.

In Europe, the number of clinical particle therapy centers has substantially increased. Currently, more than 4,000 adult patients receive particle therapy treatment annually across Europe.

In the APAC region, the rise in cancer cases, particularly among the geriatric population, technological advancements in healthcare products, and the surge in adoption of particle therapy products by hospitals and advanced cancer treatment centers, is poised to propel the market. Furthermore, the initiation of projects for particle therapy centers by key players, such as the Australian Bragg Centre for Proton Therapy and Research, is likely to contribute significantly to future market expansion in the APAC region.

Analysis of Key Players

The particle therapy market share is fragmented with the presence of a number of players. Advanced Oncotherapy plc, Danfysik A/S, Hitachi, Ltd., IBA Worldwide, Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., ProTom International, Inc., Provision Healthcare, and Varian Medical Systems, Inc., are the emerging players in the global market.

Key players have been profiled in the global particle therapy market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In January 2024, The National Association for Proton Therapy (NAPT), the foremost organization committed to enhancing patient access to advanced cancer treatments, announced the release of a study in the International Journal of Radiation Oncology-Biology-Physics. This study delves into the utilization of proton therapy for an expanding array of medical conditions and tumor sites.
  • In October 2023, The National Cancer Centre Singapore (NCCS) received a proton therapy system from Hitachi, Ltd. and Hitachi Asia Ltd., and NCCS has finished treating its first patient with it. With this, Hitachi's first proton therapy system in Southeast Asia will begin treating patients.
  • In July 2023, Hitachi, Ltd. delivered a proton therapy system to the HKSH Medical Group ("HKSH"), which includes Hong Kong Sanatorium and Hospital. The system has begun treatment, signaling the start of proton therapy treatment services in Hong Kong.

Global Particle Therapy Market Snapshot

Attribute Detail
Market Size in 2022 US$ 603.5 Mn
Forecast Value in 2031 More than US$ 1.3 Bn
CAGR 8.6%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Mn/Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • Therapy
    • Proton Therapy
    • Heavy Ion (Carbon Therapy, He, Pion, etc.)
  • Services
    • Cyclotrons
    • Synchrotrons
    • Synchrocyclotrons
  • Application
    • Pediatric Cancer
    • Lung Cancer
    • Bladder Cancer
    • Brain and Spinal Cord Tumors (BSCT)
    • Breast Cancer
    • Gastrointestinal (GI) Cancers
    • Hepatocellular Carcinoma (HCC)
    • Head and Neck Cancers (HNC)
    • Others
  • End-user
    • Hospitals
    • Academic & Research Centers
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
Companies Profiled
  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.
  • Optivus Proton Therapy, Inc.
  • Protom International, Inc.
  • Provision Healthcare
  • Varian Medical Systems, Inc.
  • Other Players

Frequently Asked Questions

How big was the global particle therapy market in 2022?

It was valued at US$ 603.5 Mn in 2022

How big will the particle therapy business be by 2031?

It is projected to reach more than US$ 1.3 Bn by the end of 2031

What will be the CAGR of the particle therapy industry during the forecast period?

The CAGR is anticipated to be 8.6% from 2023 to 2031

Which region will account for major share of the particle therapy sector during the forecast period?

North America is expected to account for largest share from 2023 to 2031

Who are the prominent particle therapy providers?

Advanced Oncotherapy plc, Danfysik A/S, Hitachi, Ltd., IBA Worldwide, Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., ProTom International, Inc., Provision Healthcare, and Varian Medical Systems, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Particle Therapy Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Particle Therapy Market Analysis and Forecast, 2017 - 2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Reimbursement Scenario

        5.3. Particle Therapy Facilities In Clinical Operations

        5.4. Average Prices, by Region, 2022

        5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)

    6. Global Particle Therapy Market Analysis and Forecast, By Therapy

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Therapy, 2017 - 2031

            6.3.1. Proton Therapy

            6.3.2. Heavy Ion Therapy (carbon therapy, He, pion)

        6.4. Market Attractiveness Analysis, By Therapy

    7. Global Particle Therapy Market Analysis and Forecast, By Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017 - 2031

            7.3.1. Pediatric Cancer

            7.3.2. Lung Cancer

            7.3.3. Bladder Cancer

            7.3.4. Brain & Spinal Cord Tumors (BSCT)

            7.3.5. Breast Cancer

            7.3.6. Gastrointestinal (GI) Cancers

            7.3.7. Hepatocellular Carcinoma (HCC)

            7.3.8. Head & Neck Cancers (HNC)

            7.3.9. Others

        7.4. Market Attractiveness Analysis, By Application

    8. Global Particle Therapy Market Analysis and Forecast, By Services

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Services, 2017 - 2031

            8.3.1. Cyclotrons

            8.3.2. Synchrotrons

            8.3.3. Synchrocyclotrons

        8.4. Market Attractiveness Analysis, By Services

    9. Global Particle Therapy Market Analysis and Forecast, By End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by End-user, 2017 - 2031

            9.3.1. Hospitals

            9.3.2. Academic & Research Centers

        9.4. Market Attractiveness Analysis, By End-user

    10. Global Particle Therapy Market Analysis and Forecast, By Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Rest of the World

        10.3. Market Attractiveness Analysis, By Region

    11. North America Particle Therapy Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Therapy, 2017 - 2031

            11.2.1. Proton Therapy

            11.2.2. Heavy Ion Therapy (carbon therapy, He, pion)

        11.3. Market Value Forecast, by Application, 2017 - 2031

            11.3.1. Pediatric Cancer

            11.3.2. Lung Cancer

            11.3.3. Bladder Cancer

            11.3.4. Brain & Spinal Cord Tumors (BSCT)

            11.3.5. Breast Cancer

            11.3.6. Gastrointestinal (GI) Cancers

            11.3.7. Hepatocellular Carcinoma (HCC)

            11.3.8. Head & Neck Cancers (HNC)

            11.3.9. Others

        11.4. Market Value Forecast, by Services, 2017 - 2031

            11.4.1. Cyclotrons

            11.4.2. Synchrotrons

            11.4.3. Synchrocyclotrons

        11.5. Market Value Forecast, by End-user, 2017 - 2031

            11.5.1. Hospitals

            11.5.2. Academic & Research Centers

        11.6. Market Value Forecast, by Country, 2017 - 2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Therapy

            11.7.2. By Application

            11.7.3. By Services

            11.7.4. By End-user

            11.7.5. By Country

    12. Europe Particle Therapy Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Therapy, 2017 - 2031

            12.2.1. Proton Therapy

            12.2.2. Heavy Ion Therapy (carbon therapy, He, pion)

        12.3. Market Value Forecast, by Application, 2017 - 2031

            12.3.1. Pediatric Cancer

            12.3.2. Lung Cancer

            12.3.3. Bladder Cancer

            12.3.4. Brain & Spinal Cord Tumors (BSCT)

            12.3.5. Breast Cancer

            12.3.6. Gastrointestinal (GI) Cancers

            12.3.7. Hepatocellular Carcinoma (HCC)

            12.3.8. Head & Neck Cancers (HNC)

            12.3.9. Others

        12.4. Market Value Forecast, by Services, 2017 - 2031

            12.4.1. Cyclotrons

            12.4.2. Synchrotrons

            12.4.3. Synchrocyclotrons

        12.5. Market Value Forecast, by End-user, 2017 - 2031

            12.5.1. Hospitals

            12.5.2. Academic & Research Centers

        12.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Therapy

            12.7.2. By Application

            12.7.3. By Services

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific Particle Therapy Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Therapy, 2017 - 2031

            13.2.1. Proton Therapy

            13.2.2. Heavy Ion Therapy (carbon therapy, He, pion)

        13.3. Market Value Forecast, by Application, 2017 - 2031

            13.3.1. Pediatric Cancer

            13.3.2. Lung Cancer

            13.3.3. Bladder Cancer

            13.3.4. Brain & Spinal Cord Tumors (BSCT)

            13.3.5. Breast Cancer

            13.3.6. Gastrointestinal (GI) Cancers

            13.3.7. Hepatocellular Carcinoma (HCC)

            13.3.8. Head & Neck Cancers (HNC)

            13.3.9. Others

        13.4. Market Value Forecast, by Services, 2017 - 2031

            13.4.1. Cyclotrons

            13.4.2. Synchrotrons

            13.4.3. Synchrocyclotrons

        13.5. Market Value Forecast, by End-user, 2017 - 2031

            13.5.1. Hospitals

            13.5.2. Academic & Research Centers

        13.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. By Therapy

            13.7.2. By Application

            13.7.3. By Services

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Rest of the World Particle Therapy Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Therapy, 2017 - 2031

            14.2.1. Proton Therapy

            14.2.2. Heavy Ion Therapy (carbon therapy, He, pion)

        14.3. Market Value Forecast, by Application, 2017 - 2031

            14.3.1. Pediatric Cancer

            14.3.2. Lung Cancer

            14.3.3. Bladder Cancer

            14.3.4. Brain & Spinal Cord Tumors (BSCT)

            14.3.5. Breast Cancer

            14.3.6. Gastrointestinal (GI) Cancers

            14.3.7. Hepatocellular Carcinoma (HCC)

            14.3.8. Head & Neck Cancers (HNC)

            14.3.9. Others

        14.4. Market Value Forecast, by Services, 2017 - 2031

            14.4.1. Cyclotrons

            14.4.2. Synchrotrons

            14.4.3. Synchrocyclotrons

        14.5. Market Value Forecast, by End-user, 2017 - 2031

            14.5.1. Hospitals

            14.5.2. Academic & Research Centers

        14.6. Market Attractiveness Analysis

            14.6.1. By Therapy

            14.6.2. By Application

            14.6.3. By Services

            14.6.4. By End-user

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2022

        15.3. Company Profiles

            15.3.1. Advanced Oncotherapy plc

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Strategic Overview

            15.3.2. Danfysik A/S

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Strategic Overview

            15.3.3. Hitachi, Ltd.

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Strategic Overview

            15.3.4. IBA Worldwide

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Strategic Overview

            15.3.5. Mevion Medical Systems, Inc.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Strategic Overview

            15.3.6. Optivus Proton Therapy, Inc.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Strategic Overview

            15.3.7. Protom International, Inc.

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Strategic Overview

            15.3.8. Provision Healthcare

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Strategic Overview

            15.3.9. Varian Medical Systems, Inc.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Strategic Overview

    List of Tables

    Table 01: Global Particle Therapy Market Value (US$ Mn) Forecast, by Therapy 2017 - 2031

    Table 02: Global Particle Therapy Market Value (US$ Mn) Forecast, by Application, 2017 - 2031

    Table 03: Global Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017 - 2031

    Table 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

    Table 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Region, 2017 - 2031

    Table 06: North America Particle Therapy Market Value (US$ Mn) Forecast, by Country, 2017 - 2031

    Table 07: North America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017 - 2031

    Table 08: North America Particle Therapy Market (US$ Mn) Forecast, by Application, 2017 - 2031

    Table 09: North America Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017 - 2031

    Table 10: North America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

    Table 11: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031

    Table 12: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017 - 2031

    Table 13: Europe Particle Therapy Market (US$ Mn) Forecast, by Application, 2017 - 2031

    Table 14: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017 - 2031

    Table 15: Europe Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

    Table 16: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031

    Table 17: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017 - 2031

    Table 18: Asia Pacific Particle Therapy Market (US$ Mn) Forecast, by Application, 2017 - 2031

    Table 19: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017 - 2031

    Table 20: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

    Table 21: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017 - 2031

    Table 22: Rest of the World Particle Therapy Market (US$ Mn) Forecast, by Application, 2017 - 2031

    Table 23: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017 - 2031

    Table 24: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

    List of Figures

    Figure 01: Global Particle Therapy Market Value (US$ Mn) Forecast, 2017 - 2031

    Figure 02: Global Particle Therapy Market Value Share Analysis, by Therapy, 2022 and 2031

    Figure 03: Global Particle Therapy Market Attractiveness Analysis, by Therapy, 2023 - 2031

    Figure 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by Proton Therapy, 2017 - 2031

    Figure 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Heavy Ion Therapy, 2017 - 2031

    Figure 06: Global Particle Therapy Market Value Share Analysis, by Application, 2022 and 2031

    Figure 07: Global Particle Therapy Market Attractiveness Analysis, by Application, 2023 - 2031

    Figure 08: Global Particle Therapy Market Value (US$ Mn) Forecast, by Pediatric Cancer, 2017 - 2031

    Figure 09: Global Particle Therapy Market Value (US$ Mn) Forecast, by Lung Cancer, 2017 - 2031

    Figure 10: Global Particle Therapy Market Value (US$ Mn) Forecast, by Bladder Cancer, 2017 - 2031

    Figure 11: Global Particle Therapy Market Value (US$ Mn) Forecast, by Brain &Spinal Cord Tumors, 2017 - 2031

    Figure 12: Global Particle Therapy Market Value (US$ Mn) Forecast, by Breast Cancer, 2017 - 2031

    Figure 13: Global Particle Therapy Market Value (US$ Mn) Forecast, by Gastrointestinal (GI) Cancers, 2017 - 2031

    Figure 14: Global Particle Therapy Market Value (US$ Mn) Forecast, by Hepatocellular Carcinoma (HCC), 2017 - 2031

    Figure 15: Global Particle Therapy Market Value (US$ Mn) Forecast, by Head & Neck Cancers (HNC), 2017 - 2031

    Figure 16: Global Particle Therapy Market Value (US$ Mn) Forecast, by Other Cancers, 2017 - 2031

    Figure 17: Global Particle Therapy Market, by Service, 2022 and 2031

    Figure 18: Global Particle Therapy Market Attractiveness Analysis, by Service, 2023 - 2031

    Figure 19: Global Particle Therapy Market Value (US$ Mn) Forecast, by Cyclotrons, 2017 - 2031

    Figure 20: Global Particle Therapy Market Value (US$ Mn) Forecast, by Synchrotrons, 2017 - 2031

    Figure 21: Global Particle Therapy Market Value (US$ Mn) Forecast, by Synchrocyclotrons, 2017 - 2031

    Figure 22: Global Particle Therapy Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 23: Global Particle Therapy Market Attractiveness Analysis, by End-user, 2023 - 2031

    Figure 24: Global Particle Therapy Market (US$ Mn), by Hospitals, 2017 - 2031

    Figure 25: Global Particle Therapy Market (US$ Mn), by Academic & Research Institutes, 2017 - 2031

    Figure 26: Global Particle Therapy Market Value Share Analysis, by Region, 2022 and 2031

    Figure 27: Global Particle Therapy Market Attractiveness Analysis, by Region, 2023 - 2031

    Figure 28: North America Particle Therapy Market Value (US$ Mn) Forecast, 2017 - 2031

    Figure 29: North America Particle Therapy Market Value Share Analysis, by Country, 2022 and 2031

    Figure 30: North America Particle Therapy Market Attractiveness Analysis, by Country, 2023 - 2031

    Figure 31: North America Particle Therapy Market Value Share Analysis, by Therapy, 2022 and 2031

    Figure 32: North America Particle Therapy Market Attractiveness Analysis, by Therapy, 2023 - 2031

    Figure 33: North America Particle Therapy Market Value Share Analysis, by Application, 2022 and 2031

    Figure 34: North America Particle Therapy Market Attractiveness Analysis, by Application, 2023 - 2031

    Figure 35: North America Particle Therapy Market Value Share Analysis, by Service, 2022 and 2031

    Figure 36: North America Particle Therapy Market Attractiveness Analysis, by Service, 2023 - 2031

    Figure 37: North America Particle Therapy Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 38: North America Particle Therapy Market Attractiveness Analysis, by End-user, 2023 - 2031

    Figure 39: Europe Particle Therapy Market Value (US$ Mn) Forecast, 2017 - 2031

    Figure 40: Europe Particle Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 41: Europe Particle Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031

    Figure 42: Europe Particle Therapy Market Value Share Analysis, by Therapy, 2022 and 2031

    Figure 43: Europe Particle Therapy Market Attractiveness Analysis, by Therapy, 2023 - 2031

    Figure 44: Europe Particle Therapy Market Value Share Analysis, by Application, 2022 and 2031

    Figure 45: Europe Particle Therapy Market Attractiveness Analysis, by Application, 2023 - 2031

    Figure 46: Europe Particle Therapy Market Value Share Analysis, by Service, 2022 and 2031

    Figure 47: Europe Particle Therapy Market Attractiveness Analysis, by Service, 2023 - 2031

    Figure 48: Europe Particle Therapy Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 49: Europe Particle Therapy Market Attractiveness Analysis, by End-user, 2023 - 2031

    Figure 50: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, 2017 - 2031

    Figure 51: Asia Pacific Particle Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 52: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031

    Figure 53: Asia Pacific Particle Therapy Market Value Share Analysis, by Therapy, 2022 and 2031

    Figure 54: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Therapy, 2023 - 2031

    Figure 55: Asia Pacific Particle Therapy Market Value Share Analysis, by Application, 2022 and 2031

    Figure 56: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Application, 2023 - 2031

    Figure 57: Asia Pacific Particle Therapy Market Value Share Analysis, by Service, 2022 and 2031

    Figure 58: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Service, 2023 - 2031

    Figure 59: Asia Pacific Particle Therapy Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 60: Asia Pacific Particle Therapy Market Attractiveness Analysis, by End-user, 2023 - 2031

    Figure 61: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, 2017 - 2031

    Figure 62: Rest of the World Particle Therapy Market Value Share Analysis, by Therapy, 2022 and 2031

    Figure 63: Rest of the World Particle Therapy Market Attractiveness Analysis, by Therapy, 2023 - 2031

    Figure 64: Rest of the World Particle Therapy Market Value Share Analysis, by Application, 2022 and 2031

    Figure 65: Rest of the World Particle Therapy Market Attractiveness Analysis, by Application, 2023 - 2031

    Figure 66: Rest of the World Particle Therapy Market Value Share Analysis, by Service, 2022 and 2031

    Figure 67: Rest of the World Particle Therapy Market Attractiveness Analysis, by Service, 2023 - 2031

    Figure 68: Rest of the World Particle Therapy Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 69: Rest of the World Particle Therapy Market Attractiveness Analysis, by End-user, 2023 - 2031

Copyright © Transparency Market Research, Inc. All Rights reserved